DNA scaffold nanoparticles coated with HPMC/EC (cas 14344-48-0) for oral delivery
-
Add time:08/08/2019 Source:sciencedirect.com
The control of the glycemic level among diabetes/T2 patients is very important for their long term survival and avoiding further complexities including micro/macrovascular diseases as well as diabetic neuropathy. Vildagliptin (VD) is a drug that has addressed these issues successfully with the desired safety portfolio. We used DNA-nanocubes for initial nano-encapsulation of VD followed by HPMC/EC coating. The results revealed the stable, smooth, spherical and nano-sized nanoparticles with improved size uniformity (from 100 to 400 nm in diameter) and encapsulation-efficiency (E.E.%) than previously reported (500–2000 nm) with the chemical compatibility evident in ATR/FTIR and DSC results. Animal experiments results revealed the improvement of incretin level in the serums due to potent DPP-4 inhibition compared to the free-VD/solution with better maintenance of glycemic levels after feeding. The safety of these HPMC/EC-DNA-VD nanoparticles was assessed through the histological-examination after completion of the treatment turn. The solvent evaporation technique provided the better coating of HPMC around DNA-core with gastro-resistant and effervescent property due to presence of NaHCO3 (0.01%) in the formulations that caused delayed delivery of VD as well as nanoparticles to the intestine, increasing the availability time of the drug and nanospheres at the target sites (intestine and blood) where DPP-4 enzyme is most abundant (to degrade the GLP-1 and GIP causing loss of control of the postprandial glycemic levels. So the availability of sustained release nanospheres near the target sites and prolonged DPP-4 inhibition improved the outcomes of the therapy.
We also recommend Trading Suppliers and Manufacturers of EC (cas 14344-48-0). Pls Click Website Link as below: cas 14344-48-0 suppliers
Prev:Plasma equilibrium based on EC (cas 14344-48-0)-driven current profile with toroidal rotation on QUEST
Next:Design of the ITER EC (cas 14344-48-0) upper launcher nuclear shielding) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- EU DEMO EC (cas 14344-48-0) system preliminary conceptual design08/10/2019
- Design of the ITER EC (cas 14344-48-0) upper launcher nuclear shielding08/09/2019
- Plasma equilibrium based on EC (cas 14344-48-0)-driven current profile with toroidal rotation on QUEST08/07/2019
- Heteroscedastic stratified two-way EC (cas 14344-48-0) models of single equations and SUR systems08/06/2019
- Demonstration of synchronous control of EC (cas 14344-48-0) TL switch and gyrotron for ITER EC (cas 14344-48-0) system08/05/2019
- Enhanced operation of the Eu EC (cas 14344-48-0) test facility08/04/2019
- EC (cas 14344-48-0)-tractability of approximation problems in function spaces defined over products of simplices08/03/2019
- Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC (cas 14344-48-0)-8042 in ERG-positive Prostate Cancer08/02/2019


